Mayobanex Pujols - 09 Feb 2026 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Chief Technology Officer
Signature
/s/ Marc Grasso, as Attorney-in-Fact
Issuer symbol
KYTX
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
11 Feb 2026, 16:30:05 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pujols Mayobanex Chief Technology Officer C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE /s/ Marc Grasso, as Attorney-in-Fact 11 Feb 2026 0002109086

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYTX Stock Option (right to buy) Award $0 +300,000 $0.000000 300,000 09 Feb 2026 Common Stock 300,000 $8.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on February 9, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive